Ketamine-Based Treatment of MDD: A Biologist’s Perspective

Journal Title: Journal of Depression and Therapy - Year 2017, Vol 1, Issue 3

Abstract

Ketamine’s potential as a fast-acting reagent to treat MDD, especially treatment-resistant depression has caught much attention recently. Although much has been learned about the biological mechanisms underlying ketamine’s effect, there are a few critical issues remained to be resolved. This mini review will briefly discuss several controversial issues that warrant further studies, regarding the molecular, physiological, psychopharmacological, and behavioral effects of ketamine. Understand how ketamine works as an anti-depressant will open the door to better understanding of MDD and its treatment.

Authors and Affiliations

Shupeng Li, Yingli Zhang, Qiang Zhou

Keywords

Related Articles

A Specific Case of Non-Specificity: Longitudinal Effects of Dysfunctional Attitudes on Depressive, Eating Disorder and Aggressive Symptoms in Children and Adolescents

An important step in the validation of disorder-specific etiological models is the examination of the predictive specificity of proposed vulnerability factors. It may advance the understanding of the emergence of comorbi...

Basal Serum Cortisol Levels, Depression and Medial Temporal Lobe Atrophy in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

Objectives: Changes in serum cortisol levels have been reported in Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI). Atrophy of Medial Temporal Lobes (MTLs) is common in both conditions. Glucocorticoids are k...

Ketamine-Based Treatment of MDD: A Biologist’s Perspective

Ketamine’s potential as a fast-acting reagent to treat MDD, especially treatment-resistant depression has caught much attention recently. Although much has been learned about the biological mechanisms underlying ketamine...

“On the Road to A Better Life”: An Innovative Suicide Prevention Program Based on The Realization of Meaningful Personal Goals

Background. Suicide prevention programs centred on reinforcing protective factors are uncommon. Aims. Since leading a meaningful life is incompatible with suicide, a 14-week program designed to help participants realize...

Depression and Executive Dysfunction in Young Adults; Implications for Therapy

The prevalence of young adults endorsing depressive symptomatology is thought to peak during late adolescence. While there has been a wealth of research assessing the relationship between decline of the prefrontal corte...

Download PDF file
  • EP ID EP262527
  • DOI 10.14302/issn.2476-1710.jdt-17-1673
  • Views 120
  • Downloads 0

How To Cite

Shupeng Li, Yingli Zhang, Qiang Zhou (2017). Ketamine-Based Treatment of MDD: A Biologist’s Perspective. Journal of Depression and Therapy, 1(3), 29-34. https://europub.co.uk/articles/-A-262527